C21 Investments Inc. (CWLXF)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-01 | Phase2 Readout | — |
| 2026-09-01 | Phase2 Readout | — |
| 2027-05-01 | Phase2 Readout | — |
Active Clinical Trials (14)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07112638 | The engAGE Project: Immersive Intergenerational Intervention to Improve Movement in Older Adults | OTHER | Active Not Recruiting | 240 |
| NCT07066033 | A Study of the Intestinal Microbiota in Children and Adolescents With Eating Disorders. A Perspective From Psychoneuroim... | OTHER | Recruiting | 158 |
| NCT07569861 | Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome | OTHER | Recruiting | 144 |
| NCT06729242 | Influence of Menstrual Cycle Phases on the Glycemic Control of Aerobic or HIIT Exercise in Adult Women With Type 1 Diabe... | OTHER | Recruiting | 40 |
| NCT06871384 | Dietary Strategy to Tackle Cognitive and Locomotor Abilities in Early Elderly Subjects | OTHER | Recruiting | 72 |
| NCT06284122 | Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 | PHASE3 | Recruiting | 790 |
| NCT02261415 | The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial | PHASE3 | Active Not Recruiting | 1,386 |
| NCT05026632 | NPI-002 Intravitreal Implant for the Delay of Cataract Progression | PHASE2 | Active Not Recruiting | 30 |
| NCT06588686 | A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. | PHASE2 | Active Not Recruiting | 378 |
| NCT03899792 | A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System... | PHASE2 | Active Not Recruiting | 36 |
| NCT03157128 | A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Me... | PHASE2 | Active Not Recruiting | 857 |
| NCT02711553 | A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer | PHASE2 | Active Not Recruiting | 309 |
| NCT06977724 | A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV... | PHASE1 | Recruiting | 36 |
| NCT05937841 | Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia | PHASE1 | Recruiting | 30 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.